The ROSE Scale-up Study: Informing a Decision About ROSE as Universal PPD Prevention (ROSES-II)
Postpartum Depression
About this trial
This is an interventional prevention trial for Postpartum Depression focused on measuring postpartum depression, antenatal depression, depression, prevention, depression prevention, pregnancy
Eligibility Criteria
Inclusion Criteria: Is aged 18 or older Is receiving prenatal services at Henry Ford Health Is between 12-32 weeks pregnant Speaks and understand English well enough to understand questionnaires when they are read aloud Has access to a telephone through owning one, a relative/friend, or an agency Is willing and able to provide the name and contact information of at least two locator persons Exclusion Criteria: Has a current major depressive episode Has current or past diagnosis of a bipolar disorder or a psychotic disorder
Sites / Locations
- Michigan State UniversityRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
ROSE (Reach Out, Stay Strong, Essentials for mothers of newborns)
Enhanced Care as Usual (CAU)
Evidence-based 5 session psychosocial intervention that has been found to prevent ~50% of postpartum depression among low-income, at risk women.
Usual care at the study site does not include postpartum depression prevention. Instead, HFHS clinics try to screen for PPD that has already occurred and refer women for mental health care. Screening for existing PPD at these clinics primarily relies on the EPDS (10+), Perinatal women who score 10+ on the EPDS are referred for mental health services. Services received depends on follow-up, severity, and the mental health wait list. Our study will exclude women meeting criteria for likely current major depressive episode at baseline and assist them in obtaining mental health care. Enhanced CAU consists of usual care + monitoring and emergency referral, as is required to fulfill ethical obligations to trial participants.